Table 3.
Perioperative results.
| Rivaroxaban group (n = 18) | Aspirin group (n = 14) | p-value | |
|---|---|---|---|
| Tourniquet time (mean ± DP) | 122.72 ± 8.44 | 119.00 ± 5.59 | 0.371 |
| 24-h drain output (mean ± SD) | 354.44 ± 276.72 | 305.71 ± 196.10 | 0.834 |
| 48-h drain output (mean ± SD) | 104.78 ± 75.69 | 124.21 ± 92.33 | 0.985 |
| HB pre (mean ± SD) | −2.98 ± 1.48 | −3.30 ± 1.13 | 0.732 |
| HT pre (mean ± SD) | −9.47 ± 4.75 | −10.18 ± 4.48 | 0.790 |
| HB post-14 days (mean ± SD) | −2.38 ± 1.24 | −2.71 ± 1.19 | 0.717 |
| HT post-14 days (mean ± SD) | −6.89 ± 3.55 | −8.04 ± 5.55 | 0.372 |
n, sample size; SD, standard deviation; DVT, deep venous thrombosis; HB, hemoglobin; HT, hematocrit.